KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Co-Diagnostics (CODX) Non-Current Debt (2017 - 2021)

Historic Non-Current Debt for Co-Diagnostics (CODX) over the last 5 years, with Q3 2021 value amounting to $30000.0.

  • Co-Diagnostics' Non-Current Debt fell 5000.0% to $30000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was $30000.0, marking a year-over-year decrease of 5000.0%. This contributed to the annual value of $30000.0 for FY2020, which is 8000.0% down from last year.
  • Co-Diagnostics' Non-Current Debt amounted to $30000.0 in Q3 2021, which was down 5000.0% from $90000.0 recorded in Q2 2021.
  • In the past 5 years, Co-Diagnostics' Non-Current Debt ranged from a high of $480000.0 in Q4 2017 and a low of $30000.0 during Q4 2020
  • In the last 5 years, Co-Diagnostics' Non-Current Debt had a median value of $135000.0 in 2019 and averaged $206287.9.
  • Its Non-Current Debt has fluctuated over the past 5 years, first soared by 90983.39% in 2018, then crashed by 8000.0% in 2020.
  • Co-Diagnostics' Non-Current Debt (Quarter) stood at $480000.0 in 2017, then plummeted by 45.83% to $260000.0 in 2018, then tumbled by 42.31% to $150000.0 in 2019, then crashed by 80.0% to $30000.0 in 2020, then changed by 0.0% to $30000.0 in 2021.
  • Its Non-Current Debt stands at $30000.0 for Q3 2021, versus $90000.0 for Q2 2021 and $120000.0 for Q1 2021.